Exchange of information on banned, hazardous chemicals and unsafe pharmaceutical products. Administrative and financial implications of the draft resolution contained in document A/C.3/35/L.54 : statement / submitted by the Secretary-General in accordance with rule 153 of the rules of procedure of the General Assembly.